ArticleVirchows Archiv : an international journal of pathology2022

Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma.

Atsushi Yamashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.